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Abstract
Background: Protein expression profiles throughout 28 days of peripheral nerve regeneration were characterized
using an established rat sciatic nerve transection injury model. Reverse phase protein microarrays were used to
identify the spatial and temporal expression profile of multiple proteins implicated in peripheral nerve regeneration
including growth factors, extracellular matrix proteins, and proteins involved in adhesion and migration. This high-
throughput approach enabled the simultaneous analysis of 3,360 samples on a nitrocellulose-coated slide.
Results: The extracellular matrix proteins collagen I and III, laminin gamma-1, fibronectin, nidogen and versican
displayed an early increase in protein levels in the guide and proximal sections of the regenerating nerve with
levels at or above the baseline expression of intact nerve by the end of the 28 day experimental course. The 28
day protein levels were also at or above baseline in the distal segment however an early increase was only noted
for laminin, nidogen, and fibronectin. While the level of epidermal growth factor, ciliary neurotrophic factor and
fibroblast growth factor-1 and -2 increased throughout the experimental course in the proximal and distal
segments, nerve growth factor only increased in the distal segment and fibroblast growth factor-1 and -2 and
nerve growth factor were the only proteins in that group to show an early increase in the guide contents. As
expected, several proteins involved in cell adhesion and motility; namely focal adhesion kinase, N-cadherin and
b-catenin increased earlier in the proximal and distal segments than in the guide contents reflecting the relatively
acellular matrix of the early regenerate.
Conclusions: In this study we identified changes in expression of multiple proteins over time linked to
regeneration of the rat sciatic nerve both demonstrating the utility of reverse phase protein arrays in nerve
regeneration research and revealing a detailed, composite spatiotemporal expression profile of peripheral nerve
regeneration.
Keywords: Peripheral nerve regeneration, Reverse phase protein array, Extracellular matrix, Proteomics, Growth
factors
Background
Peripheral nerve injury has been estimated to occur in
about 3% of trauma patients and can lead to life-long
disability [1]. Transection injuries, especially those that
result in large gaps between nerve ends, are particularly
incapacitating. While the peripheral nervous system has
the ability to regenerate, transection injuries typically
require reconstructive surgery and the restoration of
sufficient function remains a significant challenge.
Regeneration in the peripheral nervous system is a
complex process which requires the careful orchestra-
tion of multiple factors and cues to create the optimal
microenvironment for regeneration to occur [reviewed
in [2] and [3]]. Past research has shown that axons
regenerate from the proximal stump of a transected
nerve in response to tactile signals and chemotropic
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[4,5]. The cellular events underlying serial stages in per-
ipheral nerve regeneration have been described and
include Wallerian degeneration of the distal nerve fol-
lowed by regeneration events led by the migration of
Schwann cells from the distal nerve segment and axon
sprouting from the proximal nerve segment forming the
proximal growth cone [reviewed in [6] and [7]]. These
a x o n su s eb a n d so fB ü n g n e r ,f o r m e db yp r o l i f e r a t i n g
Schwann cells extending from the distal stump, as a
physical scaffold to guide their growth. Recently, Parri-
nello and colleagues reported that fibroblasts also play a
key role in peripheral nerve regeneration. More specifi-
cally, they have shown that when the nerve is severed,
ephrin-B/EphB2 signaling between fibroblasts and
Schwann cells results in cell sorting, followed by direc-
tional collective cell migration of Schwann cells out of
the nerve stumps to guide regrowing axons cross the
wound [8]. The axons and Schwann cells both respond
to and produce, trophic factors which are transported to
t h ei n j u r ys i t ew h e r et h e yh a v eg r o w t hp o t e n t i a t i n g
effects; attracting axons in a concentration guided, mod-
ality-specific and organ-specific manner [9-12]. The role
of Schwann cells following axotomy is multifaceted
including initial phagocytosis of cell debris followed by
the transfer of degraded myelin to macrophages, as part
of the degenerative process. The migration of Schwann
cells precedes the involvement of alternative cell popula-
tions activated by signals presumably released by the
cells of the proximal growth cone that in turn respond
to triggers occurring physically downstream. Such cues
for migration include growth factors and extracellular
matrix (ECM) proteins as has been demonstrated in in
vitro models of migration [13-15].
The underlying events that drive the regenerative pro-
cess have yet to be fully elucidated; although there has
been extensive research looking at both inhibitory and
promotional factors. Peripheral nerve regeneration
research efforts can be generally divided into two cate-
gories, those that evaluate materials used to create a phy-
sical scaffold or nerve guide to direct the regenerating
nerve (also referred to as tubulation) [16] and those that
alter the environment of the regenerating nerve. Environ-
mental alteration, for example through the use of cul-
tured cells or growth factors, is often combined with a
guide, to create an optimal regenerative environment
[reviewed in [17] and [18]]. While early studies used con-
duits composed of decalcified bone, more recent guides
have consisted of a range of synthetic and biological
materials [reviewed in [17] and [18]]. The ideal guide
material is one that retains sufficient mechanical strength
for surgical manipulation while providing permeability
and bioresorbability so as not to act as a barrier for cell
infiltration and nerve regeneration [[19-24] and others].
While many studies have shown promising results, they
have yet to produce an alternative that is superior to the
nerve autograft, the current gold standard. Although
autografting is the standard of care when repairing loss
of length of large multifascicular nerve injuries, it is not
without disadvantages, namely neuroma formation, una-
vailability of donor nerve, conflicts of modality and
donor site morbidity [25-28].
Research focused on altering the microenvironment of
the regenerating nerve has also shown promise. A num-
ber of molecules have been shown to enhance nerve
regeneration including nerve growth factor (NGF)
[29-32], fibroblast growth factor (FGF) [33-37], glial
growth factor [38], platelet-derived growth factor [39],
ciliary neurotrophic factor (CNTF) [40-43] and ECM
components such as fibronectin, collagen and laminin
[44-49]. The action of each class of molecule can be
direct, influencing axon growth by binding to axonal cel-
lular components or indirect by guiding axon growth and
modeling a microenvironment permissive for the promo-
tion of regeneration. Despite the advances reported in
experimental models which have combined the different
facets of polymer guides and the delivery of relevant
molecules directly to the regenerative site, full functional
restoration has not been attained. The events underlying
peripheral nerve regeneration represent tightly orche-
strated interactions between a diverse array of molecules
within a tightly regulated temporal sequence. Thus it is
difficult to adopt a reductionist approach to understand
such a complex series of events.
To further enhance our understanding of the regenera-
tive process it would be beneficial to gain a more global
view of the cellular and biochemical events that underlie
peripheral nerve regeneration from both a spatial and
temporal perspective by evaluating protein expression in
different segments of the regenerating nerve over time.
Proteomic techniques such as Western blots and immu-
nohistochemistry haven been used successfully for spa-
tiotemporal profiling, but these techniques are typically
low-throughput and most reports focus on just a few
proteins. Due to differences in experimental models, it is
difficult to combine observations between studies. Pro-
teomics techniques such as two-dimensional gel electro-
phoresis and mass spectrometry have been instrumental
in identifying candidate proteins involved in peripheral
nerve regeneration and have demonstrated the complex-
ity of protein expression in the regenerating nerve
[50-53]. The reverse phase protein array (RPPA) is a
powerful proteomic technique that enables the measure-
ment of protein levels in a large number of samples
simultaneously [54-60]. By arraying lysates created from
distinct portions of the regenerating nerve at distinct
time points we were able to create a spatiotemporal
expression profile of the peripheral nerve regeneration
Bryan et al. Proteome Science 2012, 10:9
http://www.proteomesci.com/content/10/1/9
Page 2 of 16process on a single microscope slide. Each slide requires
only a small amount of lysate (~2 nl per spot), so the
material from a single experiment can be used to evaluate
the expression profile of hundreds of proteins.
In this study we evaluate the use of RPPAs in periph-
eral nerve regeneration using an established rat sciatic
nerve transection injury model combined with a poly-
ethylene nerve guide. The non-permeable, non-degrad-
able polyethylene guide was selected for this study over
a resorbable guide to simplify the harvesting of regener-
ated tissue. Previous studies by our group using this
model have reproducibly resulted in regenerated nerve
cables within 4-8 weeks [61] and the series of events
leading to regeneration in a similar silicone guide model
are well described [62]. The expression of 15 proteins
known to be involved in various aspects of the regenera-
tive process including growth factors, ECM proteins,
and adhesion and motility proteins was profiled in mul-
tiple locations and at multiple time points.
Results
Validation of antibodies for use in RPPA
All antibodies were tested for their suitability for use in
RPPA by western blot analysis (Figure 1 and data not
shown). Total protein lysates from excised nerves were
pooled and separated by gel electrophoresis. Confirma-
tion of the utility of each antibody for use in the RPPA
setting was determined by the detection of a single pre-
dominant band by western blot. An example blot with a
representative selection of the antibodies used is shown
in Figure 1.
Reverse phase protein arrays
The proximal and distal ends of the severed sciatic
nerve, along with the solid contents of the guide, were
harvested at different time points following axotomy
and tissue was prepared for RPPA. Tissue lysates were
arrayed in a 10-point, 2-fold dilution series on a single
nitrocellulose-coated microscope slide, with tissue con-
trols corresponding to the day 0 excised sciatic nerve
from that animal. All samples from all animals used in
this study were printed on every slide. The expression
level of 15 different proteins was measured in the tissue
lysate preparations. Figure 2 shows the processed RPPA
for growth associated protein 43 (GAP-43) (A) as well
as the extrapolated protein level as a function of time
for each of the regions (proximal, guide and distal) (B).
Expression profile of the selected protein panel
throughout nerve regeneration
Protein expression profiles throughout the 28 day
experimental period are displayed in Figures 3, 4, and 5.
The antibody panel selected for this study is divided
into three groups. The first group is adhesion and cell
motility consisting of E- and N-cadherin, b-catenin, and
focal adhesion kinase (FAK) (Figure 3). The growth fac-
tors NGF, FGF-1, FGF-2, epidermal growth factor (EGF)
and CNTF comprise the second group (Figure 4). ECM
proteins laminin, fibronectin, collagen I/III, nidogen and
versican make up the third group (Figure 5). While
Figure 1 Antibody Validation: Validation of selected antibodies in
western blot analysis showing detection of a single band for
fibronectin (A), N-cadherin (B), b-catenin (C), E-cadherin (D), laminin
g-1 (E), nidogen (F), versican (G), FGF-2 (H), and CNTF (I).
B
B
Figure 2 GAP-43 RPPA:( A) RPPA probed with GAP-43 antibody
showing an increase in protein expression over a 28-day
regenerative period. (B) A graphic representation of the microarray
showing the expression levels of GAP-43 over time in each
segment.
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Page 3 of 16Figure 3 Adhesion and Motility Protein Expression:E x p r e s s i o n
profiles of the adhesion and motility group of study proteins
divided into proximal, guide and distal segments. Time (in days) is
plotted on the X-axis and log normalized data on the Y axis.
Figure 4 Growth Factor Protein Expression: Expression profiles of
the growth factor group of study proteins divided into proximal,
guide and distal segments. Time (in days) is plotted on the X-axis
and log normalized data on the Y axis.
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regeneration with functional effects spanning more than
one of these groups, it is grouped with the adhesion and
motility proteins. A summary of expression of the com-
plete panel of proteins under study is shown in Figure 6
presented in a heatmap format.
Adhesion/motility associated proteins
Members of the classic cadherin family, E- and N-cad-
herin, displayed an overall increase in expression
throughout the course of regeneration. In the proximal
and distal segments of the regenerating nerve this
increase was significant for E-cadherin when the expres-
sion level from day 0 (intact nerve) was compared with
day 28 (q-values of 0.022 and 0.002 respectively). The
change in N-cadherin expression between day 0 and day
28 was significant in the distal portion only (q-value
0.036). Interestingly, the levels of N-cadherin in the
proximal segment appeared to peak at day 14 and the
expression level at 14 days was significantly higher than
baseline (q-value 0.024). Both E-cadherin and N-cad-
herin displayed continued elevated expression up to 21
days in the distal segment followed by a plateau in
expression up to 28 days. There was no significant
change in E- or N-cadherin levels in the guide contents
when comparing the day 0 to the day 28 time point.
The guide segment results compare intact nerve (day 0
expression levels) to the regenerate which, at least for
the early time points, contains no nerve. Since the guide
segment contains only regenerated tissue, the lack of
significant difference from day 0 represents a return to
the baseline protein levels seen in intact nerve. For N-
cadherin this return to baseline occurs by day 14 while
fluctuations in E-cadherin expression were recorded
throughout the 28 day regenerative period with above
baseline peaks at ≤ 7 and 21 days and troughs that
approached baseline levels at 14 and 28 days. In con-
trast, b-catenin, an integral member of the cadherin
complex, showed a significant change from baseline
only at day ≤ 7 in the proximal (q-value 0.024) and dis-
tal (q-value 0.029) segments, but in the guide tissue dis-
played peaks and troughs that mirrored N-cadherin, but
were opposite to that recorded for E-cadherin in the
same site.
FAK has been shown to promote neurite outgrowth
and in this model displayed an increase in expression
throughout the regenerative process in the proximal and
distal segments with an initial, significant drop at day ≤
7 (q-value 0.002) and recovery to higher than baseline
levels by day 14 in the guide portion. The overall
Figure 5 ECM Protein Expression: Expression profiles of the ECM
group of study proteins divided into proximal, guide and distal
segments. Time (in days) is plotted on the X-axis and log
normalized data on the Y axis.
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Figure 6 Hierarchical Clustering Analysis in Heatmap Format: Proximal (A), distal (B), and solid guide content (C) samples are shown for
each protein over time points of ≤ 7, 14, 21, and 28 days. Colors corresponding to relative levels of expression are shown at the bottom of
each heatmap.
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Page 6 of 16increase in FAK levels between day 0 and day 28 was
significant in the distal segment only (q-value 0.016).
In the distal nerve stump GAP-43 levels increased
rapidly up to 14 days followed by a relative plateau for
the remainder of the experimental course. A sharp
increase in GAP-43 was also seen in the proximal nerve
up until 7 days with a slower, but marked increase
through 28 days. In contrast, GAP-43 protein level
showed no significant change from baseline throughout
the course of the experiment in the guide contents indi-
cating an early up-regulation of GAP-43 in the regener-
ating tissue. The overall increase in GAP-43 between
day 0 and day 28 was significant in the proximal and
distal segments only (q-values 0.002 and 0.001
respectively).
Growth factors
Amongst the molecules included in the growth factor
group, a significant increase in the expression level of
FGF-1, FGF-2 and EGF was recorded between 0-14 days
in the regenerating distal nerve followed by a plateau in
expression between 14 and 28 days (the q-value for the
day 0 to day 14 comparisons were 0.007, 0.004, and 0.009
respectively). In the proximal nerve segment, expression
levels of each of the aforementioned growth factors con-
tinued to rise past 14 days although none of the changes
after day 14 reached significance. Comparing day 0 to day
28, both FGF-1 and FGF-2 demonstrated a significant
increase in protein levels in the proximal nerve segment,
but EGF did not (q-values for FGF-1 and FGF-2 were
0.006 and < 0.001 respectively). Interestingly, significantly
reduced EGF expression was recorded in the guide tissue
over the 28 day regeneration period (q-value < 0.001). In
contrast, a comparison of day 0 to day 28 protein levels
for FGF-1 and FGF-2 did not reveal a significant change in
the guide contents indicating a return to the baseline levels
of intact nerve and both proteins displayed a temporary
increase in expression that peaked at 14 days and reached
significance for FGF-2 (q-value 0.037).
CNTF displayed only a limited, insignificant increase in
expression in the proximal and distal segments relative to
the other growth factors in the study and, like EGF, sig-
nificantly reduced expression in the guide tissue between
day 0 and day 28 (q-value < 0.001). However, unlike EGF,
CNTF did not decrease throughout the entire regenera-
tive period, instead displaying an increase in expression
at 21 days followed by a further decline at 28 days.
N G Fd i s p l a y e dab i p h a s i ce x p r e s s i o np r o f i l ei nt h e
regenerating distal nerve with significant peaks occur-
ring at 14 and 28 days post-axotomy (q values < 0.001
and 0.006 respectively when comparing day 14 and day
28 to baseline). No significant change in NGF expres-
sion was recorded in the proximal segment or guide
compartment of the regenerating nerve between baseline
and day 28. In the guide compartment the level of NGF
was not significantly different than baseline by day ≤ 7
indicating an early recovery of NGF protein in this
segment.
Extracellular matrix proteins
T h eE C Mp r o t e i n sh a v eb e e ns h o w nt op l a yar o l ei n
growth promotion and cell migration involving direc-
tional guidance, both important processes in nerve
regeneration. Fibronectin displayed a significant increase
in protein levels over baseline at 21 and 28 days in the
proximal segment (q-values 0.014 and 0.024 respec-
tively), 21 days in the distal segment (q-value 0.036),
and even at the earliest time point of ≤ 7 days no signif-
icant change from intact nerve in the guide segment. A
significant increase from baseline levels was observed in
the guide segment at day 14 and day 21 (q-values <
0.001 and 0.023 respectively). Laminin displayed a sig-
nificant increase in both the proximal and distal seg-
ments between 0 and 28 days (q values 0.009 and <
0.001 respectively), whereas the guide contents did not
show a significant change when comparing the same
time points indicating a return to the levels of intact
nerve. Like fibronectin, day ≤ 7 laminin expression was
also not significantly different than baseline in the guide
segment. Collagen I/III had a distinct temporal sequence
of expression which peaked at days ≤ 7a n d2 1i nt h e
proximal and guide segments, respectively, and was sig-
nificantly reduced compared to baseline in the distal
segment (q-value 0.011) at 14 days followed by restora-
tion to expression levels recorded in the intact nerve for
the remainder of the experimental course. At day ≤ 7
the guide segment had recovered to baseline collagen I/
III expression levels. Nidogen and versican protein levels
were elevated overall although the change was only sig-
nificant in the distal segment (q-values for both compar-
i s o n sw e r e0 . 0 1 4 ) .N i d o g e n ,ap o t e n t i a t o ro fS c h w a n n
cell proliferation, showed biphasic expression with peaks
at ≤ 7 and 21 days post-axotomy most notably in the
guide segment indicating an early increase even higher
than baseline expression. Versican protein levels were
elevated early in the proximala n dg u i d es e g m e n t sw i t h
a significant increase at 14 days (q-values 0.011 and ≤
0.001 respectively) followed by a slow decline with levels
increased, but not significantly different than baseline at
28 days. In the distal segment protein levels were signifi-
cantly lower than baseline at day ≤7a n dd a y2 8( q -
values 0.018 and 0.014 respectively).
Discussion
Significant advances in promoting peripheral nerve
regeneration have been made on multiple fronts includ-
ing the use of bioresorbable polymer guides to serve as
conduits and delivery devices for different molecules
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erative process. Knowledge of the expression pattern of
proteins essential to regeneration have helped predict
the best candidates for exogenous administration, how-
ever this information must be pooled from individual
studies with variable models in order to generate a glo-
bal expression profile. In this study we used RPPA to
facilitate the simultaneous temporal and spatial expres-
sion mapping of key proteins in the nerve regeneration
process using a rat sciatic nerve transection injury
model. The benefit of RPPA analysis is that many sam-
ples can be analyzed simultaneously. Since this techni-
que requires very little starting material, it also enables
the analysis of a large number of proteins. The limited
number of proteins reported in this study was not due
to a limitation in source material, but instead the limited
availability of antibodies that cross-react with rat pro-
teins and were suitable for use in RPPA. In this study
every antibody was first validated by western blot and
any antibody that did not produce a single predominant
band by western was excluded. Although an analysis of
15 proteins does not represent the full capability of the
RPPA technique, we believe that this paper provides sig-
nificant insight into the regulation of these proteins and
sets the stage for further proteomic evaluation using this
model.
The phases of regeneration in a non-permeable, non-
resorbable nerve guide chamber have been described and
include a fluid, matrix, cellular, and axonal phase [62].
Within a day after axotomy and guide insertion the guide
fills with fluid that contains neuronotrophic factors. A
mainly acellular matrix forms within a week followed by
the immigration of cells (including Schwann, fibroblast,
and endothelial) from both the proximal and distal nerve
stumps after 7-14 days. Finally, after 2 weeks, axonal
elongation begins with myelination occurring a few days
later [62]. According to this description, the first time
point used in the current study (≤ 7 days) would capture
the regenerative process at the matrix phase with the sec-
ond time point (14 days) representing the cellular phase.
The final time points of 21 and 28 days represent the
axonal phase with the later time point likely to have a
higher percentage of myelinated axons.
P r o t e i ne x p r e s s i o na n a l y s i si nt h eg u i d ec o n t e n tc o m -
pares intact nerve (day 0 expression levels) to the regen-
erate which initially contains no nerve. Based on the
described regenerative process, an early increase (mani-
fested as a return to baseline levels) in the proteins
included in the ECM category would be expected in the
guide portion of the regenerate. Indeed, all of the ECM
proteins studied demonstrate not only a return to base-
line, but an increase in expression at ≤ 7d a y so v e r
intact nerve. In contrast, several of the cellular proteins
such as b-catenin, FAK, and N-cadherin show an initial
decline from the protein level of intact nerve in the
guide segment and peak later at day 14 corresponding
with the cellular phase of regeneration. This initial
decline from baseline is to be expected since the guide
segment does not contain intact nerve at the earlier
time points. Interestingly, the growth factors represent a
mixed group in the guide portion with an early return
to baseline or increase over intact nerve for NGF, FGF-1
and FGF-2, and overall decline in the levels of CNTF
and EGF in the solid guide contents. Overall, we saw a
decrease in the expression of all growth factors in the
guide contents from day 21 to day 28, the time at which
axonal migration and myelination is underway. This is
consistent with a previous study that demonstrated that
the neuronotrophic activity of the fluid that fills the
guide chamber is highest in the first few days of regen-
eration suggesting that the role of at least some of these
molecules peaks early in the regenerative process [63].
The general patterns of protein expression seen by
RPPA analysis in this study are consistent with estab-
lished knowledge and warrant more thorough analysis.
GAP-43 is present in the presynaptic terminal of novel
neuromuscular junctions [64], and has been shown to be
expressed in regenerating axons following nerve injury
[65-68]. GAP-43 reportedly plays a promotional role in
nerve sprouting post axotomy [69]. In our model we
found an overall increase in GAP-43 levels throughout
the experiment. Several groups have reported an early
up-regulation of GAP-43 protein or mRNA following
nerve injury [68,70,71]. We observed a pattern of early,
increased expression in both the proximal and distal
nerve segments that appeared to plateau by 14 days. At
its peak, the distal nerve segment has a higher expres-
sion level of GAP-43 than the proximal nerve and the
guide contents show no significant change in GAP-43
compared to intact nerve even at the earliest time point.
These results differ slightly than those of Plantinga et al.
who reported no increase in proximal GAP-43 mRNA
levels, but this difference might be explained by differ-
ences in the experimental models, most notably that the
nerve ends in the former study were coagulated and
ligated while ours were allowed to regenerate. The dis-
crepancy could also be explained by poor correlation
between mRNA and protein levels [68].
Members of the cadherin family and the associated
proteins that form the functional cadherin/catenin com-
plex have been shown to play important roles in cell
migration. E-cadherin is associated with the adherens
junctions of the Schmidt-Lanterman incisures and is
unique because it forms an autotypic adherens-type
junction confined to the plasma membrane of a single
Schwann cell [72]. Expression of E-cadherin is increased
following injury in a variety of models [73,74]. Consis-
tent with these studies, we found elevated expression of
Bryan et al. Proteome Science 2012, 10:9
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the distal and proximal segments, day 28 levels remain
significantly higher than baseline while in the guide they
return to the baseline level of intact nerve.
As cadherin complexes assemble, there is a distinct
hierarchy of catenin association led by E-cadherin/b-
catenin binding followed by additional catenin members.
Interestingly, b-catenin that binds to E-cadherin within
the cadherin complex, revealed no significant change in
expression profile throughout the regenerative process
in the proximal and distal segments in our study. b-
catenin levels in the guide decreased significantly at ≤ 7
days followed by a rebound to baseline levels and a sig-
nificant but lower decline from baseline at 21 and 28
days. Our observation is in contrast to a report by
Hatoko et al. that showed increased b -catenin expres-
sion in the graft portion of a nerve graft model of regen-
eration, however this difference might be explained by
the fact that the previous study was evaluating expres-
sion in intact nerve grafts where our study included just
the regenerated contents within a hollow guide [75].
N-cadherin has been shown to be present on axonal
growth cones in vitro [76] and is thought to play a role
in the stabilization of myelin sheaths based on its distri-
bution and low expression levels in normal nerves
[77,78]. Several groups have reported increased N-cad-
herin levels at 15 days post-axotomy [79,80]. We con-
firmed an increase in N-cadherin expression during
regeneration that reached statistical significance at 14
days in the proximal segment and 21 days in the distal
segment, but did not observe significantly higher expres-
sion in the distal segment than the proximal segment as
reported by Thorton and colleagues [80]. This discre-
pancy may be explained by differences in the models
used where in the Thorton study the nerve ends were
capped following axotomy and not allowed to regener-
ate. We also showed that in the distal stump, N-cad-
herin expression peaks at 21 days which is later than
the 14 day peak in the proximal segment and suggests a
temporal sequence of events. The guide contents show
an initial (day ≤ 7) decrease in N-cadherin expression
followed by a higher than baseline peak at 14 days and
slight decline similar to the pattern observed in the
proximal segment. Since N-cadherin has been shown to
be expressed around regenerated axons [79,81], the drop
in N-cadherin expression in the guide contents at day ≤
7 is likely due to the absence of axon-axon or axon-
Schwann cell interactions at this location at such an
early stage in the regenerative process.
FAK has been identified as a regulator of Schwann cell
proliferation in the developing nervous system [82] and
inhibition of FAK activity inhibited neurite growth in an
in vitro model [83]. In the current study, FAK expres-
sion was increased in both the distal and proximal nerve
segments although only the increase in the distal por-
tion reached statistical significance. In the guide there
was a drop in FAK levels at day ≤ 7, likely due to the
absence of intact nerve and corresponding reduction in
Schwann cells at this time point, followed by a return to
baseline for the remainder of the experiment. Activation
of FAK leads to autophosphorylation at Tyr397 and an
analysis of activated FAK levels will be needed to further
elucidate the role of FAK in regeneration.
Numerous growth factors have been implicated in per-
ipheral nerve regeneration with different members of the
FGF family playing a prominent role in this process
[reviewed in [84] and [85]]. Several groups have reported
enhancement of nerve regeneration using FGF-1 and -2
[33,34,86-89] and FGF-2 levels have shown to be up-regu-
lated following peripheral nerve injury at both the mRNA
and protein levels [[90-92] and others]. Surprisingly, a
decrease in FGF-1 protein levels or mitogenic activity after
crush or transection has also been reported [93,94]. We
observed an increase in FGF-1 and FGF-2 levels in both
the proximal and distal ends of the regenerating nerve.
Interestingly, in our study, FGF-1, FGF-2, and NGF were
the only growth factors to show an early increase in the
guide contents suggesting that these factors play a role in
the initial phase of the regenerative process.
While EGFR mRNA and protein levels increase fol-
lowing nerve injury [95], and an EGF homolog has been
shown to promote axonal regeneration in CNS neurons
in vitro [96], Dubuisson et al. found that exogenous
EGF did not enhance peripheral nerve regeneration in
their model [97]. We found that EGF protein levels
were increased significantly in the distal segment. The
proximal segment showed an insignificant increase and
there was an overall decrease in EGF in the solid con-
tents of the guide. This differential in EGF expression
could imply a role for EGF in the maturation of periph-
eral nerve tissue rather than in the more active state of
regeneration.
NGF is a neurotrophin that has been shown to play a
role in nerve regeneration in a large number of studies.
Rich et al. demonstrated improved peripheral nerve
regeneration with added NGF, as have others [30-32,98].
NGF mRNA and protein has been shown to be
expressed at low levels in healthy nerves and up-regu-
lated in the distal, but not the proximal stump upon
injury [94,99]. In our model NGF expression remained
at baseline levels in the regenerating proximal segment.
In contrast, NGF expression rapidly returned to the
baseline level of intact nerve in the guide tissue and was
significantly elevated in the distal segment by 14 days
p o s t - a x o t o m ya n da tt h ee n do ft h ee x p e r i m e n tf o l l o w -
ing an unexplained dip at 21 days. This supports the
earlier findings that NGF is linked to events in the
guide and distal segment of the regenerating nerve.
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and axonal regeneration with exogenous administration
[41,42,100,101], but Ito and colleagues reported low
CNTF mRNA levels post-axotomy and a similar obser-
vation has been made in a crush model [102,103]. In
our study CNTF displayed only a limited, insignificant
increase in expression in the proximal and distal seg-
ments and an overall significant decrease in protein
levels within the solid guide contents consistent with
these later reports.
ECM components play an essential role in nervous
system development and repair. Schwann cells assemble
a fibrillar network that consists of fibronectin, laminin,
and collagen type IV which is thought to play a role in
proliferation [104]. The different ECM proteins likely
exert their influence on different facets of nerve regen-
eration influencing multiple cellular processes. Fibronec-
tin has previously been shown to be a potent
chemoattractant for Schwann cell migration in vitro and
in vivo [13,14,105,106] and fibronectin protein and
mRNA levels were found to be elevated in several mod-
els of nerve injury [107-109]. We found an increase in
fibronectin levels that reached significance at day 21
proximally and distally. Within the guide there was an
early return to baseline levels by day ≤ 7 and significant
increase over baseline by day 14. Fibronectin levels
increased more rapidly in the proximal segment than
the distal segment and were significantly higher at ≤ 7
days in the proximal segment consistent with the find-
ings of Lefcort et al. who demonstrated highest fibro-
nectin expression in the vicinity of the injury at the
same time point [107].
Laminins are key components of the basal lamina and
laminin has been shown to play a prominent promo-
tional role in nerve regeneration in vivo by regulating
axonal growth [110,111]. The laminin gamma-1 (B2)
chain is one of the most abundant of the 12 known
chains that compose the laminin heterotrimer and is
present in laminin isoforms 1-4 and 6-11 [112]. There is
conflicting evidence regarding gamma-1 mRNA expres-
sion with Wallquist and colleagues showing an up-regu-
lation after sciatic transection (most notably in the
proximal stump) and Doyu et al. reporting a decrease
when normalized to total RNA levels [113,114]. In our
experiment, gamma-1 proteine x p r e s s i o ni n c r e a s e ds i g -
nificantly between day 0 and day 28 both proximally
and distally, and there was an early return to baseline
gamma-1 levels in the guide itself. Our results are most
consistent with those of Wallquist [113]. In both our
model and the Wallquist model the nerve ends were
allowed to regenerate, while in the Doyu studies they
were not [113,114]. This difference in experimental
design may explain the conflicting results.
Collagen is the major component of the ECM and
several groups have shown an increase in collagen I and
III mRNA after nerve injury as well as functional
improvement with exogenous administration
[108,115-118]. In the current study, we used an antibody
that detected both collagens I and III and found no sig-
nificant change in levels between day 0 and day 28 in
the proximal and distal segments. In the guide there
was an early return to baseline protein levels by day ≤ 7
followed by a significantly higher than baseline expres-
sion level at day 21 and a significantly lower level than
baseline level by day 28 suggesting that, at least at the
protein level, the role of collagens I/III is predominantly
in the regenerating portion of the nerve.
Nidogen is a component of the basement membrane.
Nidogen protein and mRNA levels have been shown to
be up-regulated post transection injury [15] and nidogen
appears to be required for neurite outgrowth after axot-
omy [119]. Our results support these findings as we
found an increase in nidogen levels early in the regen-
erative process with a significant increase by ≤ 7 days in
all segments. The guide contents displayed a biphasic
increase in the guide with significant peaks at ≤ 7a n d
21 days and baseline levels at the 14 and 28 days.
Clearly nidogen plays a role in many aspects of the
regenerative process.
The chondroitin sulphate proteoglycan, versican, iso-
form V2 has been shown to be an inhibitor of axonal
growth while V1 has been shown to promote neurite
outgrowth [120-122]. We looked at the versican V0/V1
isoforms and found a significant increase in the proxi-
mal and guide segments that peaked at 14 days followed
by a slight decline to the end of the study period consis-
tent with these reports. Interestingly, versican levels
remained low throughout the experiment in the distal
segment suggesting that versican plays more of a role in
the proximal region of the regenerating nerve during
the timeframe we analyzed.
Not surprisingly, cluster analysis of protein expression
over time did not always separate the proteins into the
functional groups we defined, but other interesting pat-
terns were revealed (Figure 6). In the proximal section,
increased expression of N-cadherin was recorded
throughout the regenerative period consistent with its
reported role in cell migration and expression in cells of
mesenchymal origin. In embryoid bodies, the timing and
spatial distribution of versican expression correlates with
the appearance and localization of N-cadherin [123]. In
this study, N-cadherin and versican expression clustered
together in the proximal segment of the regenerating
nerve, suggesting that the regenerative events in the
proximal nerve may mimic the processes that occur in
early development.
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particularly interesting ast h i sc o m p a r e si n t a c tn e r v e
(day 0 expression levels) to the regenerate which, at
least for the early time points, contains no nerve. It is
not surprising that a greatern u m b e ro fp r o t e i n ss h o w
an initial decline in this segment, but interestingly many
are up-regulated even at the earliest time point. In the
guide segment groupings more closely follow functional
roles. For example, all of the ECM proteins are repre-
sented in a single branch (early up-regulated expression)
and the majority of the adhesion and motility proteins
in the other (early down-regulated expression). The pat-
tern of expression correlates to the temporal role of
these proteins groups in the regenerative process where
ECM proteins play an early role in the matrix phase and
adhesion and motility proteins a later role in the cellular
phase of regeneration. GAP-43 is clustered in the up-
regulated branch and grouped closely with laminin. A
functional relationship between GAP-43 and laminin
has been implicated in several other studies and this
expression pattern may reflect the complex role of
GAP-43 in the regenerative process [124,125].
Conclusions
The expression of multiple cellular and extracellular
molecules is finely orchestrated and integrated leading
to the regeneration of a new nerve. Past work using this
or similar models of peripheral nerve regeneration have
taken a reductionist approach evaluating the contribu-
tion of individual or small numbers of proteins in the
regenerative process. The RPPA approach taken in this
study allows expression profiling of multiple proteins
from a large number of samples simultaneously. In this
study we focused on proteins known to be involved in
the regenerative process and with known expression
profiles. The results both validated previous observations
and provided new detail and complexity, but the appli-
cation can be easily expanded to include any protein
with a suitable, validated antibody including posttransla-
tional modifications such as phosphorylation. In this
s t u d yw eh a v ed e m o n s t r a t e dt h a tR P P Ai sar e l i a b l e ,
high-throughput approach for the analysis of overall
protein expression profiles with the potential to identify
the temporal sequence of events underlying complex,
multifaceted, biological processes.
Methods
Surgical procedure
All animal experiments were performed with the
approval of the Institutional Animal Care and Use Com-
mittee at Lahey Clinic. Forty male Sprague Dawley rats
weighing between 225-250 g served as the model for
nerve guide repair. All animals were anesthetized via an
intraperitoneal injection of 45 mg kg
-1 sodium
pentobarbital. All underwenta ni n i t i a ls u r g e r yd u r i n g
which the right sciatic nerve was exposed via a three
centimeter incision made just posterior to the femoral
head. The dissection was carried down through the glu-
teal muscle at which point the sciatic nerve was identi-
fied. The remainder of the dissection was performed
under an operating microscope at 30 × magnification.
This same approach was carried out during a second
harvesting procedure.
A length of at least 20 mm of nerve was exposed. A
10 mm section was removed via sharp transection with
straight micro-scissors leaving at least a 5 mm proximal
and distal sciatic nerve stump. A 14 mm long polyethy-
lene nerve guide (1.67 mm ID, Becton Dickinson) was
sutured in place with 10-0 nylon suture, using a hori-
zontal mattress stitch. The suture was placed 2 mm
from the end of the guide and through the epineurium
on each respective nerve stump. The full circumference
of each stump was therefore drawn entirely inside the
guide with 2 mm of length lying inside each end of the
guide, resulting in the proximal and distal stumps posi-
tioned 10 mm apart. The 10 mm resected section of
nerve was divided into two 5 mm sections (5 mm to act
as a per-animal control, and 5 mm to be used for anti-
body validation) and the two sections were placed in
individual tubes, and frozen immediately in liquid nitro-
gen. The gluteal muscle was then closed with three bur-
ied interrupted 3-0 chromic sutures and the skin was
closed with a running 4-0 braided polyglycolic acid
suture.
At each time point (≤ 7, 14, 21, and 28 days), 10 rats
underwent a second proceduret oh a r v e s tt h ep r o x i m a l
and distal nerve ends and the contents of the guide. All
adhesions on the guide were carefully taken down with
sharp dissection under the operating microscope. Sharp
transection of the proximal and distal stump was carried
o u t ,5m mf r o me a c he n do ft h eg u i d e ,w i t hs t r a i g h t
micro-scissors. The entire specimen, proximal and distal
stumps within the guide, was taken out as one piece.
The 10-0 nylon sutures were cut and the remaining tis-
sue was separated into proximal and distal nerve stumps
and solid guide contents. Proximal and distal segments
included a total of 7 mm of nerve (2 mm of stump
within the guide and 5 mm of additional nerve). At each
time point of ≤ 7, 14, 21, and 28 days there were 5, 2, 6,
and 4 rats with solid material spanning the guide,
respectively (see Table 1 for experimental overview).
Solid guide content was defined as any matrix or tissue
that could be macroscopically retrieved from the lumen
of the nerve guide. The guide content segment was
comprised of only regenerated material and not the
nerve stumps themselves. Only tissue from animals with
solid guide content was included in the analysis. All tis-
sue was frozen immediately in liquid nitrogen.
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Nerve lysate for antibody validation was prepared by
crushing a pooled sample of the excised normal 5 mm
nerve segments under liquid nitrogen, using a mortar and
pestle. The finely ground tissue was lysed in hot sample
buffer (2 × ESB - 0.08 M Tris, pH 6.8; 0.07 M SDS, 10%
glycerol, 0.001% bromophenol blue and 1 mM CaCl2) and
sheared through a 26-gauge needle. b -mercaptoethanol
(1%) was added to each sample which was boiled for 5
min. The resulting lysate was loaded across the top of a
7.5% polyacrylamide resolving gel, with one lane contain-
ing a marker. Proteins were transferred overnight onto
nitrocellulose. Membranes were blocked in 10% milk in
TBS with 0.05% Tween-20, cut into strips and placed on
primary antibody overnight at 4°C. Blots were washed in
TBS with 0.05% Tween-20, three times for 15 min each,
and secondary antibody linked to horseradish peroxidase
was incubated with the blots for 60 min at room tempera-
ture. Blots were then washed as described above and
developed with an ECL kit (Amersham, Arlington Heights,
IL). Only antibodies that produced a single band by wes-
tern blot analysis were used for RPPA.
Antibodies
Validated antibodies used were: NGF (Epitomics, Burlin-
game, CA); Nidogen and FGF1 (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA); CNTF and FAK (Millipore,
Billerica, MA); FGF2, Fibronectin, GAP-43, E-cadherin
and b-catenin (BD Biosciences, San Jose, CA) EGF and
laminin-1 gamma-1 (R&D Systems, Minneapolis, MN);
Collagen Type I/III (Calbiochem, San Diego, CA); Versi-
can (Sigma-Aldrich, St. Louis, MO); and N-cadherin
(Zymed, San Francisco, CA). The manufacturer of the
fifteen antibodies as well as the concentrations used in
RPPA and western blot are shown in Table 2.
Preparation of tissue lysates
Each nerve sample was crushed under liquid nitrogen
with a clean mortar and pestle and suspended in 1.0 ml
ice-cold PBS and centrifuged at 4000 rpm for 2 min.
After removing the PBS, a volume of lysis buffer, com-
posed of 9 M Urea, 4% Chaps, 2% Pharmalyte pH 8.0-
10.5 and 65 mM Dithiothreitol, equal to the size of the
pellet, was added and aspirated up and down 3 times.
Samples were centrifuged at 14,000 rpm for 30 min.
T h es u p e r n a t a n tw a sc o l l e c t e da n ds t o r e da t- 8 0 ° Ca n d
the pellet was discarded. All steps following the initial
PBS wash were performed at 4°C. Ten, 2-fold serial dilu-
tions were made from each lysate with a buffer contain-
ing 6 M urea, 2.7% CHAPS, 1.3% Pharmalyte (pH 8.0-
10.5), and 43.6 mM Dithiothreitol [126,127].
Reverse-phase protein arrays
S a m p l e sw e r ea r r a y e du s i n gt h eA u s h o n2 4 7 0s o l i dp i n ,
contact microarrayer equipped with 185 μmp i n s
(Aushon BioSystems, Billerica, MA). The print matrix
was a nitrocellulose-cast glass slide (Grace BioLabs,
Bend, OR). Each slide contained 10, 2-fold serial
Table 1 Experimental Overview
Number of Animals Included in Day 0 (Baseline)
Measurements
Number of Rats Harvested at
End Point
Number of Rats with Solid Guide Contents
at End Point
Day ≤
7
40 10 5
Day
14
10 2
Day
21
10 6
Day
28
10 4
At each time point proximal, distal and solid guide contents were harvested from each animal. Only tissue from animals with solid guide content was included in
the analysis
Table 2 Antibody Name, Vendor, and Dilutions Used for
Western Blotting and RPPA Applications
Antibody Name Vendor Dilution
NGF-b Epitomics 1:500
Nidogen-1 (H-200) SCBT 1:500
CNTF (4-68) Millipore 1:100
FGF2 (basic) BD Biosciences 1:500
FGF1 (acidic) SCBT 1:100
EGF R & D Systems 1:250
Laminin-1 gamma1 R & D Systems 1:1000
Collagen type I/III Calbiochem 1:300
Fibronectin BD Biosciences 1:5000
GAP-43 BD Biosciences 1:1000
FAK Millipore 1:500
Versican V0/V1 Sigma-Aldrich 1:1000
E-cadherin BD Biosciences 1:500
N-cadherin Zymed 1:500
b-catenin BD Biosciences 1:1000
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cate totaling 3,360 lysate spots per slide. All printing
was carried out at 80% relative humidity.
Developing
Printed nitrocellulose-coated slides were washed for two
15-min periods in deionized water. Slides were blocked
for 1 h in I-Block (Life Technololgies-0.2% I-Block,
0.01% Tween-20 in phosphate buffered saline) with con-
tinuous shaking at room temperature. Immunostaining
of microarrays was performed on an automated stainer
(Autostainer Plus, Dako, Carpinteria, CA) using a tyra-
mide-based catalyzed signal amplification system
according to the manufacturer’s protocol (K1500, Dako,
Carpinteria, CA). A negative control was included using
a non-specific antibody solution (Dako, Carpinteria, CA)
substituting for the primary antibody.
Image processing & quantification
The slides were scanned at 2400 dpi resolution in an
uncompressed, 16-bit TIFF image format using an opti-
cal flatbed scanner. Images were processed by the P-
SCAN and ProteinScan (version 0.21) programs written
using Matlab software (MathWorks, Natick, MA) by the
National Institutes of Health (NIH campus, Bethesda,
MD). Outliers traceable to defects in the arrays were
eliminated and the data were analyzed. The numerical
output for each sample was generated by a modified
Dose Interpolation algorithm, DI25 [128]. ProteinScan is
a program package that automates the modified DI algo-
rithm. The DI25 value of each nerve sample was normal-
ized for total protein concentration determined by
colloidal gold staining.
Statistical analysis
T h ep r o t e i ni n t e n s i t yd a t aw a sl o g - t r a n s f o r m e dt o
ensure data normality. To investigate the spatial and
temporal differences in the protein expression levels, a
linear mixed effects model was applied to each protein
separately. The models contained fixed effects for differ-
ent times and sample types and are adjusted for baseline
protein expression levels. To account for correlated data
structure random rat effect was used in the models. To
determine which particular times and samples were sig-
nificantly different, Scheffe’st e s t[ 1 2 9 ]w a su s e d .T h e
significance results were presented as q-values, false dis-
covery rate computed based on p-values to adjust for
multiple testing [[130,131], see Additional file 1-q
values]. All statistical analyses were performed using R
version 2.9.1 [132] and R packages nlme [133] and q-
value [134]. The clustering and heatmaps were produced
using dChip software [135-137]. Heatmap data was row-
standardized to have a mean of 0.
Additional material
Additional file 1: q-values; The statistical significance of expression
data was determined and results are presented as q values, false
discovery rate adjusted p-values.
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